| 
		        
			        |  |  
			        |  |  
					| Авторизация |  
					|  |  
			        |  |  
			        | Поиск по указателям |  
			        | 
 |  
			        |  |  
			        |  |  
			        |  |  
                    |  |  
			        |  |  
			        |  |  |  | 
		|  |  
                    | Lydyard P.M., Whelan A., Fanger M.W. — Instant Notes in Immunology |  
                    |  |  
			        |  |  
                    | Предметный указатель |  
                    | | Complement      24—27 Complement activation      24—26 80—81
 Complement cleavage products      26—27 81—82
 Complement components      24—25 81
 Complement system      24—27 80—82
 Complement system, activation      24—26 80—81
 Complement system, complement proteins      24 25 81
 Complement system, functions      24 26—27 81—82
 Complement system, regulation      24 27 156
 Congenital (inherited) immunodeficiency      225—228
 Conglutinin      32
 Constant (C) regions      63—65 71—72 75
 Contact hypersensitivity      250 252—253
 Coomb's test      277—278
 Corticosteroids      109 205 208
 Corticotrophin      109 112
 Corticotrophin releasing hormone (CRH)      164
 CR2      98—99
 Crohn's disease      269
 Cross-matching      205 207—208
 Cross-reactivity      113 115—116
 CTL      see cytolytic T cells
 CTLA-4      150
 CXC chemokines      87 90—91
 Cyclophosphamide      208
 Cyclosporin A      204—205 208 272—273
 Cysteinyl-leukotrienes      242
 Cytokeratin      185 187
 Cytokine receptors      111
 Cytokine receptors, sIL-1 RA      111
 Cytokine receptors, SIL-12R      112
 Cytokine receptors, sIL-6R      111
 Cytokine receptors, sTNFR      111
 Cytokines      85—93
 Cytokines, chemokines      85 90—91
 Cytokines, cytokine families      87—91
 Cytokines, cytokine receptor targeting      92—93
 Cytokines, cytokine treatment      92—93
 Cytokines, cytokines in the clinic      92—93
 Cytokines, function of      85
 Cytokines, interferons      87—88
 Cytokines, lymphokines      87—89
 Cytokines, monokines      87 89—90
 Cytokines, nomenclature      85—86
 Cytolytic T cells (CTL)      123 126 167—168 170 172 175 178
 Cytophilic antibodies      65
 Cytosol      107 108
 Cytosolic pathogens      107—108
 Cytotoxic hypersensitivity      244—247
 Cytotoxic T lymphocytes (CTLs)      see cytolytic T cells
 Decay-accelerating factor (DAF)      24 27 226
 Defensins      13 32
 Degranulate      18—19 239 241
 Delayed type hypersensitivity (DTH)      250—253
 Dendrites      20
 Dendritic cells      20—21
 Development of the immune system      49—61
 Development of the immune system, antibodies in the newborn      60—61
 Development of the immune system, B cell development      55—59
 Development of the immune system, development of immunoglobulin diversity      55—56 70—77
 Development of the immune system, functional B cell molecules      55—57
 Development of the immune system, generation of T cell diversity      52—53
 Development of the immune system, germinal centres as sites for B cell maturation      55 57—58
 Development of the immune system, immunity in the newborn      60—61
 Development of the immune system, lymphocytes in the newborn      60
 Development of the immune system, positive and negative selection      52 54 103 147—148
 Development of the immune system, stromal cells      49—50
 Development of the immune system, the common stem cell      49
 Development of the immune system, the role of cytokines      49—51
 Di George syndrome      225 227
 Diabetes mellitus      260
 Dimeric IgA      677—669 119—120
 Diphtheria      212 214 221
 Direct immunofluorescence      279—281
 Diversity      70—77 102—103
 DNA      217 219—220 265
 DNA Vaccines      217 219—220
 Drugs and autoimmune reactions      256 257 261
 Echinococcus      168
 Edema      109
 Edward Jenner      211
 Efferent lymphatics      41
 Elephantitis      173
 ELISPOT      282
 Endocrine system      164
 Endocytosis      13
 Endoplasmic reticulum      36
 Endosomes      97
 Endothelial cells      48 86 90
 Endotoxins      30 109 169 178
 Enzyme-Linked Immunoabsorbent Assays (ELISA)      279
 Eosinophil chemotactic factors      242
 Eosinophils      19 22 82 109 161 241 269
 Eotaxin      174
 Epinephrine      241
 Epithelial cells      2 30
 Epitopes      9
 Epstein — Barr virus      159 177
 Erythrocytes      22
 Escherkhia coli      4 177
 Exocytosis      19
 Exogenous pathway      104
 Exotoxins      109 169
 Experimental allergic encephalomyelitis      271
 External defences      2—4
 External defences, microbial products and competition      4
 External defences, physical barriers      2 3
 External defences, secretions      2
 Extracellular pathogens      108
 Extrathymic development of T cells      53
 Fab fragments      64
 Factor B      25
 Factor D      25
 Factor H      25
 Factor I      25
 Familial grafting      208
 Farmer's lung      249
 Fas ligand (FasL)      126 151 184
 Fatty acids      12
 Fc fragment      64
 Fc receptors      15 16 22 31 60 268
 Fc receptors for IgE      80
 Fc receptors for IgG      80
 Fc region of IgA      80
 Fc region of IgG      80
 FcyRII (CD32)      142
 Fetal liver      181
 Fetal transplant      205
 Fetus      38
 Fever      87 89
 Fibrinogen      28 29
 Fibroblasts      30 49 89
 Filariasis      173
 FK506      208
 Flow cytometry      279
 Fluorescence Activated Cell Sorter      279
 Follicles      40
 Follicular dendritic cells      20 40
 Fractalkine      90
 Freund's adjuvant      219
 Fungal infections      170 211 223
 Fv libraries      284
 Gas gangrene      216
 gastrointestinal tract      3 18 60 68 159
 Gene rearrangement      52 70
 Generation of Diversity      52 55 71 105
 Generation of T cell diversity      52 100
 Genitourinary tracts      2 4
 Germ line genes      71 76 100
 Germinal centers      117
 
 | Glandular fever      159 Gliadin      260
 Glucans      97
 Glucocorticoids      112 164 227
 Glycoproteins      63
 Gm markers      78
 GM-CSF      87 130
 Golgi apparatus      36
 Goodpasture's disease      246
 gpl20      230
 Graft versus host reactions      198
 Gram negative bacteria      3 96
 Gram positive bacteria      3 96
 Granulocyte colony stimulating factor (G-CSF)      49
 Granuloma      168 251
 Granzymes      16 124
 Graves' disease      244
 Group A ?-hemolytic streptococci      116
 Guanine nucleoside binding      90
 Gut-associated lymphoid tissue (GALT)      5 8 43
 H and L chains      64
 H influenzae      177
 H1 and H2 receptors      242
 Haplotype      105
 Haptens      11
 Hayfever      239
 Heat shock proteins      259
 Helicobacter pylori      167
 Helminthes      168 212
 Hematopoiesis      49
 Hemolytic Disease of the Newborn      159
 Hemophilus influenzae      60 215
 Hemopoietic stem cell (HSC)      49 193
 Heparin      109
 Hepatitis A      215
 Hepatitis B virus      177 181 214
 Hepatocytes      25 29
 HER-2-neu      190 222
 Hereditary angioedema      226
 Herpes simplex virus      215
 HHV8      230
 High endothelial venules      41
 Histaminase      22
 Histamine      22 109 168 241
 HLA (human leukocyte antigens)      104 200
 HLA genes      206
 HLA system      197
 HLA-C      16
 HLA-DP, -DR, and -DQ      105
 Hormones      7
 Human immunodeficiency virus (HIV)      1 6 229
 Human papilloma virus      194
 Humoral immunity      33 67 119 225
 Hybridoma cells      83 284
 Hydrophilic interactions      64
 Hylauronic acid      177
 Hyper-IgM syndrome      225
 Hypermutation of variable region genes      55
 Hypersensitivity      237—253
 Hypersensitivity, allergens      243
 Hypersensitivity, antigens causing      241
 Hypersensitivity, autoantigens      244
 Hypersensitivity, classification      244
 Hypersensitivity, common antigens      241
 Hypersensitivity, contact sensitivity      250
 Hypersensitivity, desensitisation      242
 Hypersensitivity, diseases associated with      249
 Hypersensitivity, drugs      242
 Hypersensitivity, effector phase      239
 Hypersensitivity, IgE mediated      239
 Hypersensitivity, IgG and IgM mediated      244
 Hypersensitivity, immune complex mediated      248
 Hypersensitivity, immunotherapy      239
 Hypersensitivity, inflammatory mediators      242
 Hypersensitivity, mechanisms      248
 Hypersensitivity, rhesus incompatibility      245
 Hypersensitivity, sensitisation phase      239
 Hypersensitivity, serum sickness      248
 Hypersensitivity, stimulatory hypersensitivity      244
 Hypersensitivity, T cell mediated      251
 Hypersensitivity, transfusion reactions      244
 Hypersensitivity, tuberculin reaction      251
 Hypersensitivity, Type 1      239—243
 Hypersensitivity, Type 2      244—247
 Hypersensitivity, Type 3      248—249
 Hypersensitivity, Type 4      250—253
 Hypophysectomy      165
 Hypothalmus-pituitary-adrenal-axis (HPA)      164
 ICAMS      110 134
 Idiotype network      78 149 157 164 255
 IFN
  177 IFN
  30 110 117 189 216 IgA      3 63 117
 IgD      55 63 75 98
 IgE      19 63 80 109 117 239
 IgG      3 63 113
 IgGl      117
 IgGl, IgG2, IgG3, IgG4 subclasses      67
 IgM      63 75 98 113 117
 IL-1      28 30 40
 IL-10      112 184
 IL-12      87 110
 IL-18      110
 IL-2      17
 IL-3      89 130
 IL-4      112 117
 IL-5      19 89 118
 IL-6      28 89 110
 IL-7      40
 IL-8      87 90
 Ileum      43
 Immediate hypersensitivity      238
 Immune complex disease      167
 Immune complex mediated hypersensitivity      238
 Immune complexes      22 110 121 248
 Immune responses to tumours      183
 Immune senescence      229
 Immune surveillance      183
 Immune Thrombocytopenia Purpura (IIP)      268
 Immunity in the newborn      60
 Immunity in the newborn, antibodies in the newborn      60
 Immunity in the newborn, lymphocytes in the newborn      60
 Immunity to infection      167—163
 Immunity to infection, antigenic variation      175
 Immunity to infection, avoidance of recognition      175
 Immunity to infection, bacteria      170
 Immunity to infection, damage caused by pathogens      167
 Immunity to infection, fungi      170
 Immunity to infection, immunity to different organisms      170—174
 Immunity to infection, inactivation of immune effector mechanisms      175
 Immunity to infection, infection and its consequences      167
 Immunity to infection, microbial habitat and immune defence      167
 Immunity to infection, pathogen defence strategies      175—178
 Immunity to infection, pathogen protective mechanisms      167
 Immunity to infection, protozoa      170
 Immunity to infection, viruses      170
 Immunity to infection, worms      170
 Immunization      214—216
 Immunization, active      214
 Immunization, mucosal      214
 Immunization, passive      214
 Immunization, systemic      214
 Immunoassay      279
 Immunoblotting      279
 Immunodeficiency      6 223—235 258
 Immunodeficiency, cell-mediated immunity      233
 Immunodeficiency, complement system      223
 Immunodeficiency, diagnosis and treatment      232—235
 Immunodeficiency, evaluation      233
 Immunodeficiency, family history      233
 
 | 
 |  |  |  | Реклама |  |  |  |  |  |